• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在电子病历中重新利用抗菌药物管理工具来管理 COVID-19 患者。

Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.

机构信息

Department of Pharmacy Services, Yale New Haven Hospital, New Haven, Connecticut.

Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Infect Control Hosp Epidemiol. 2020 Nov;41(11):1335-1337. doi: 10.1017/ice.2020.281. Epub 2020 Jun 8.

DOI:10.1017/ice.2020.281
PMID:32507113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7308631/
Abstract

During the COVID-19 pandemic, the antimicrobial stewardship module in our electronic medical record was reconfigured for the management of COVID-19 patients. This change allowed our subspecialist providers to review charts quickly to optimize potential therapy and management during the patient surge.

摘要

在 COVID-19 大流行期间，我们的电子病历中的抗菌药物管理模块进行了重新配置，以用于管理 COVID-19 患者。这一变化使我们的专家医生能够快速查看图表，以在患者激增期间优化潜在的治疗和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/767d/7308631/f3e5187c474c/S0899823X20002810_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/767d/7308631/f3e5187c474c/S0899823X20002810_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/767d/7308631/f3e5187c474c/S0899823X20002810_fig1.jpg

相似文献

1
Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.在电子病历中重新利用抗菌药物管理工具来管理 COVID-19 患者。
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1335-1337. doi: 10.1017/ice.2020.281. Epub 2020 Jun 8.
2
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.降钙素原作为重症监护病房中新冠肺炎患者抗生素管理工具的应用
J Glob Antimicrob Resist. 2020 Sep;22:782-784. doi: 10.1016/j.jgar.2020.07.017. Epub 2020 Jul 25.
3
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
4
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
5
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
6
Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship.2019冠状病毒病脓毒症：推动抗生素合理使用
Chest. 2020 Nov;158(5):1833-1834. doi: 10.1016/j.chest.2020.07.023. Epub 2020 Jul 21.
7
Antimicrobial stewardship: a COVID casualty?抗菌药物管理：新冠疫情的牺牲品？
J Hosp Infect. 2020 Nov;106(3):401-403. doi: 10.1016/j.jhin.2020.10.002. Epub 2020 Oct 9.
8
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).新型冠状病毒2型感染（新冠肺炎）中的浆细胞样淋巴细胞
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
9
Sex differences in COVID-19 course and outcome: progesterone should not be neglected.COVID-19病程及预后的性别差异：孕酮不容忽视。
J Appl Physiol (1985). 2020 Nov 1;129(5):1007-1008. doi: 10.1152/japplphysiol.00740.2020.
10
EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.新冠病毒肺炎患者体内的促红细胞生成素：不止是一种促红细胞生成激素。
Am J Kidney Dis. 2020 Sep;76(3):441. doi: 10.1053/j.ajkd.2020.06.002. Epub 2020 Jun 10.

引用本文的文献

1
Translational Success and Pharmacoeconomic Lessons of Pandemic-Driven Drug Repurposing.大流行驱动的药物重新利用的转化成功与药物经济学经验教训。
Cureus. 2025 May 29;17(5):e85033. doi: 10.7759/cureus.85033. eCollection 2025 May.
2
Endemic High-Risk Clone ST277 Is Related to the Spread of SPM-1-Producing during the COVID-19 Pandemic Period in Northern Brazil.地方性高危克隆株ST277与巴西北部新冠疫情期间产SPM-1菌株的传播有关。
Microorganisms. 2023 Aug 11;11(8):2069. doi: 10.3390/microorganisms11082069.
3
The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.

本文引用的文献

1
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
2
Covid-19 - Navigating the Uncharted.新冠疫情——探索未知领域。
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.
3
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
2019年冠状病毒病（COVID-19）对抗菌药物管理药师队伍的影响：一项多中心调查。
Antimicrob Steward Healthc Epidemiol. 2022 Apr 7;2(1):e56. doi: 10.1017/ash.2022.37. eCollection 2022.
4
Leveraging antimicrobial stewardship programs in response to the coronavirus disease 2019 (COVID-19) public health emergency.利用抗菌药物管理计划应对2019冠状病毒病（COVID-19）公共卫生紧急情况。
Antimicrob Steward Healthc Epidemiol. 2022 Mar 14;2(1):e41. doi: 10.1017/ash.2022.34. eCollection 2022.
5
SHEA statement on antibiotic stewardship in hospitals during public health emergencies.医疗保健流行病学学会关于公共卫生紧急情况期间医院抗生素管理的声明。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1541-1552. doi: 10.1017/ice.2022.194. Epub 2022 Sep 14.
6
The impact of COVID-19 on antimicrobial stewardship programme implementation in hospitals - an exploration informed by the Consolidated Framework for Implementation Research.COVID-19 对医院抗菌药物管理计划实施的影响 - 基于实施研究综合框架的探索。
J Hosp Infect. 2022 Nov;129:144-152. doi: 10.1016/j.jhin.2022.08.005. Epub 2022 Aug 23.
7
Strategies to Improve Perioperative Communication During the COVID-19 Pandemic.改善2019冠状病毒病大流行期间围手术期沟通的策略
AORN J. 2022 Jun;115(6):537-545. doi: 10.1002/aorn.13689.
8
A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19.一项关于COVID-19患者抗生素处方的回顾性评估及潜在抗生素管理目标的研究。
JAC Antimicrob Resist. 2021 Nov 5;3(4):dlab170. doi: 10.1093/jacamr/dlab170. eCollection 2021 Dec.
9
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.COVID-19 与抗菌药物管理：经验教训、最佳实践和未来影响。
Int J Infect Dis. 2021 Dec;113:103-108. doi: 10.1016/j.ijid.2021.10.001. Epub 2021 Oct 5.
10
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat. urgently needed metallo-β-lactamase inhibitors: an ignored global threat.
Lancet Infect Dis. 2022 Jan;22(1):e28-e34. doi: 10.1016/S1473-3099(20)30868-9. Epub 2021 Jul 8.
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
6
The "epic" challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology.优化抗菌药物管理的“史诗”挑战：电子病历和技术的作用。
Clin Infect Dis. 2013 Oct;57(7):1005-13. doi: 10.1093/cid/cit318. Epub 2013 May 10.